Adaptyv Bio
Switzerland - EpalingesBiotechnology
Focus: Adaptyv Bio is a next-generation protein foundry based in Switzerland specializing in oncology therapeutics. The company is publicly listed and actively hiring across biology, IT, and operations—signaling active growth stage.
Profile data last refreshed 8h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
34+4 this month
Stable — net +4 jobs in 30d
6 added, 2 removed. Backfill posture.
Should You Work at Adaptyv Bio?
AI assessmentAdaptyv Bio offers upside potential for technologists and early-stage scientists seeking platform-level impact in oncology, but limited clinical/commercial proof points mean higher execution risk than established mid-caps.
Why Work Here
- Active hiring across 33 open roles in biology, IT, and operations indicates growth-stage investment and infrastructure building.
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Adaptyv Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.